The initiation of coverage by JMP Securities with a Market Outperform rating is a positive endorsement for Inovio Pharmaceuticals, suggesting that the analyst sees the stock performing better than the broader market. The setting of a price target provides a specific goal that can influence investor expectations and potentially drive short-term price movement.